Zhiqiang Yang, Ph.D., is a Senior Director, Medicinal Chemistry, Deerfield Discovery and Development, and joined the Firm in 2023. Prior to Deerfield, Dr. Yang was an Associate Director, Medicinal Chemistry for PTC Therapeutics. Before joining PTC, he co-founded Angex Pharmaceuticals where he was Vice President of Chemistry and the Chief Operating Officer. Dr. Yang began his drug discovery career at Merck where he spent 13 years working on both small molecules and peptides of which several progressed into clinical stages. He holds a B.S. in Chemistry from Peking University in China, and a Ph.D. in Organic Chemistry from the University of Wisconsin-Madison.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.Read More
Supporting companies across the healthcare ecosystem with flexible funding models…Read More
Infrastructure of SupportCure, Deerfield’s Innovation Campus Deerfield Discovery & Development External Operations
InvestmentBusiness Development Portfolio Oversight Therapeutics Healthcare Services Medical Technologies Public Structured Finance Trading
Deerfield Discovery & Development (3DC)
Deerfield InstituteData Analytics and Development Information Research Information Technology
FeaturedIllumina and Deerfield Management partner to accelerate drug development PE Hub: Every disease is a finite puzzle Deerfield Management Announces XSeed Award Winners Break Into the Boardroom Fills Over 50 Healthcare Board Seats With Women Leaders
News by TypePress Release Insights
News by IndustryTherapeutics Healthcare Services Medical Technologies Cross-industry
Portfolio CompaniesTherapeutics Medical Technologies Healthcare Services and IT View All
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.Read More
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.Read More Meet the Foundation Team
Foundation Partners by FocusChildren's Health Diversity Initiatives Maternal Health View All
Founded Diversity ProgramsBreak into the Boardroom Fellowships Women in Science
Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.Read More Meet the Cure Team Join the Cure Email List
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.Events at the Cure
Zhiqiang Yang, Ph.D.
Qing Xie, Ph.D.
Qing Xie, Ph.D., is a Director, Computational Biology, Deerfield Discovery and Development and joined the Firm in 2022. Prior to Deerfield, Dr. Xie spent 22 years at GlaxoSmithKline (GSK), most recently as Associate Director, Computational Biology. Dr. Xie holds a B.S. in Biochemistry from Anhui University, in China, an M.S. in Biochemistry from the Beijing Institute of Pharmaceutical Chemistry, in China, and a Ph.D. in Molecular Biology from the University of Delaware.